Relay Therapeutics (RLAY) Intangibles (2021 - 2025)

Relay Therapeutics (RLAY) has reported Intangibles for 5 consecutive years, with $2.3 million the latest figure, recorded in Q1 2025.

• In Q1 2025, Intangibles changed 0.0% year-over-year to $2.3 million; the TTM figure through Mar 2025 stood at $2.3 million (changed 0.0% YoY), while the FY2024 annual figure was $2.3 million, changed 0.0% from the prior year.
• Intangibles held at $2.3 million in Q1 2025 per RLAY's latest filing, from $2.3 million in the prior quarter.
• Across five years, Intangibles topped out at $2.3 million in Q2 2021 and bottomed at $2.3 million in Q2 2021.
• Historically, Intangibles has averaged $2.3 million across 5 years, with a median of $2.3 million in 2021.
• On a YoY basis, Intangibles climbed as much as 0.0% in 2022 and fell as far as 0.0% in 2022.
• Relay Therapeutics' Intangibles stood at $2.3 million in 2021, then changed by 0.0% to $2.3 million in 2022, then changed by 0.0% to $2.3 million in 2023, then changed by 0.0% to $2.3 million in 2024, then changed by 0.0% to $2.3 million in 2025.
• Business Quant data shows RLAY's Intangibles at $2.3 million in Q1 2025, $2.3 million in Q4 2024, and $2.3 million in Q3 2024.